Education
About Us
Working with TipRanks
Follow Us
Crescita Therpeutc J (TSE:CTX)
TSX:CTX
Total Valuation
Crescita Therpeutc has a market cap or net worth of C$8.56M. The enterprise value is C$1.84M.
Market CapC$8.56M
Enterprise ValueC$1.84M
Share Statistics
Crescita Therpeutc has 18,613,937 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,613,937
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Crescita Therpeutc’s return on equity (ROE) is -0.17 and return on invested capital (ROIC) is -18.60%.
Return on Equity (ROE)-0.17
Return on Assets (ROA)-0.13
Return on Invested Capital (ROIC)-18.60%
Return on Capital Employed (ROCE)-0.20
Revenue Per Employee244.75K
Profits Per Employee-34.38K
Employee Count80
Asset Turnover0.90
Inventory Turnover2.46
Valuation Ratios
The current PE Ratio of Crescita Therpeutc is 17.0. Crescita Therpeutc’s PEG ratio is -0.09.
PE Ratio17.0
PS Ratio0.57
PB Ratio0.71
Price to Fair Value0.71
Price to FCF7.26
Price to Operating Cash Flow6.56
PEG Ratio-0.09
Income Statement
In the last 12 months, Crescita Therpeutc had revenue of 19.58M and earned -2.75M in profits. Earnings per share was -0.14.
Revenue19.58M
Gross Profit9.61M
Operating Income-3.21M
Pretax Income-2.76M
Net Income-2.75M
EBITDA-1.33M
Earnings Per Share (EPS)-0.14
Cash Flow
In the last 12 months, operating cash flow was 2.03M and capital expenditures -635.00K, giving a free cash flow of 1.40M billion.
Operating Cash Flow2.03M
Free Cash Flow1.40M
Free Cash Flow per Share0.08
Dividends & Yields
Crescita Therpeutc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.04
52-Week Price Change-19.30%
50-Day Moving Average0.46
200-Day Moving Average0.50
Relative Strength Index (RSI)39.21
Average Volume (3m)12.63K
Important Dates
Crescita Therpeutc upcoming earnings date is Mar 25, 2026, TBA (Confirmed).
Last Earnings DateNov 5, 2025
Next Earnings DateMar 25, 2026
Ex-Dividend Date―
Financial Position
Crescita Therpeutc as a current ratio of 2.77, with Debt / Equity ratio of 3.86%
Current Ratio2.77
Quick Ratio2.04
Debt to Market Cap0.04
Net Debt to EBITDA6.33
Interest Coverage Ratio-49.46
Taxes
In the past 12 months, Crescita Therpeutc has paid -14.00K in taxes.
Income Tax-14.00K
Effective Tax Rate<0.01
Enterprise Valuation
Crescita Therpeutc EV to EBITDA ratio is -2.05, with an EV/FCF ratio of 1.78.
EV to Sales0.14
EV to EBITDA-2.05
EV to Free Cash Flow1.78
EV to Operating Cash Flow1.01
Balance Sheet
Crescita Therpeutc has C$8.31M in cash and marketable securities with C$484.00K in debt, giving a net cash position of C$7.82M billion.
Cash & Marketable SecuritiesC$8.31M
Total DebtC$484.00K
Net CashC$7.82M
Net Cash Per ShareC$0.42
Tangible Book Value Per ShareC$0.73
Margins
Gross margin is 51.98%, with operating margin of -16.42%, and net profit margin of -14.04%.
Gross Margin51.98%
Operating Margin-16.42%
Pretax Margin-14.12%
Net Profit Margin-14.04%
EBITDA Margin-6.81%
EBIT Margin-13.78%
Analyst Forecast
The average price target for Crescita Therpeutc is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast26.79%
EPS Growth Forecast―